Next-Generation Sequencing

The tests will be developed to identify NSCLC patients with ALK fusions and EGFR Exon20 insertion mutations who respond to mobocertinib or brigatinib.

Shares of Illumina fell in afternoon trading on the Nasdaq following a brief rise after the market open.

UK-based ATDBio will develop new oligonucleotide-tagged microbeads for use in droplet-based single-cell RNA sequencing, to be evaluated by researchers at Oxford.

The single-cell and spatial genomics firm is seeking to raise more money from the markets a year after its $410.8 million IPO.

The Medicare Administrative Contractor will cover ctDNA tests if the patient has a personal history of colorectal cancer.

Some of the firms will receive money to speed up test development, while others will use the funds to expand their testing and manufacturing capacity.

he single-cell microbiome sequencing firm has raised a total of ¥1.5 billion in equity financing since its founding in 2018.

Created by BloodPAC members, the resource may serve as a set of generic analytical protocols to help define industry standards for developing liquid biopsy tests.

Golden Gateway, which operates throughout the Asia Pacific region, will exclusively distribute UST's linked read library preparation kit in Australia.